Stock Market Impact: Shares of Elekta AB (ST:EKTAb) fell more than 14% on the day of the earnings release as investors reacted to a 15% YoY decline in Q4 order intake and sales miss, despite margin improvement.
Listed Companies and Sectors: The radiotherapy equipment maker reported Q4 order intake of SEK 4.57 bn (‑15% YoY, constant‑currency), net sales SEK 4.76 bn (‑4.7% vs estimate SEK 4.99 bn). Adjusted EBIT SEK 902 m, margin 18.9% (272 bps above consensus). Adjusted EPS SEK 0.57 (‑61.2% vs consensus SEK 1.47). Full‑year 2025/26 net sales SEK 16.72 bn (‑7% reported, +1% constant‑currency), adjusted EBIT SEK 2.05 bn, adjusted EPS SEK 2.42 (‑25.9% vs consensus SEK 3.27). Dividend unchanged at SEK 2.40 per share. Net debt reduced to SEK 3.19 bn from SEK 3.47 bn.
Investment Flows: No direct mention of FDI/FPI; however, weaker order intake in emerging markets may signal reduced capital spending in those regions.
Interest Rates, Inflation, and Liquidity: No explicit monetary policy content; the company highlighted cost‑saving measures delivering annualised savings > SEK 500 m and strongest cash flow in five years (SEK 1.39 bn).
Fiscal or Monetary Policy: No fiscal or monetary policy announcements; guidance for FY 2026/27 includes expected constant‑currency sales growth and further EBIT margin improvement.
